Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Category : Search result: pharmaceutical services company
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Gujarat Caste Certificate Services Challenged in GARC Report
The latest Gujarat Administrative Reforms Commission report questions the efficiency of caste certificate services under CM leadership, revealing significant delays and bureaucratic hurdles affecting citizens.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
Microsoft Azure Global Outage: Configuration Error Blamed
Microsoft confirms a major configuration error caused widespread Azure outage affecting users globally. Learn how services are being restored and what caused the massive disruption.
Microsoft Azure Outage Hits Office & Gaming Services
Major Microsoft services including Azure cloud platform, Office 365, and gaming apps experience widespread disruption. Microsoft confirms outage and launches investigation.
Microsoft Azure & 365 Down in Global Outage
Microsoft's cloud services including Azure and Office 360 experience widespread disruption, affecting businesses and users worldwide. Downdetector reports massive spike in outage complaints.
Cognizant Exploring India IPO Listing
Cognizant Technology Solutions is actively exploring an initial public offering (IPO) in India, marking a significant strategic move that could reshape its relationship with the massive Indian market where it employs over 250,000 professionals.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
India's Services Boom Masks 40M Job Crisis
India's booming services sector hides a worrying employment paradox. While 40 million new jobs are projected, only 30% will be in high-value services, creating a massive skills mismatch and threatening economic growth.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Texas Sues Johnson & Johnson Over Tylenol-Autism Link
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Sanofi India appoints Deepak Arora as Managing Director
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India probes anti-dumping of TB drugs from China, Thailand
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
TechEnsGlobal & GBS Launch SOC Services in Saudi Arabia
Leading cybersecurity firm TechEnsGlobal partners with GBS to deliver state-of-the-art Security Operations Center services across Saudi Arabia, addressing growing digital threats in the region.
TCS denies losing $1B Marks & Spencer contract
Tata Consultancy Services refutes claims of losing massive UK retail contract, clarifying position amid market speculation about cybersecurity incident impact.
Punjab bans 112 substandard drugs in health safety drive
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
Urban Company's 10-Min Service Festival Launches
Urban Company launches groundbreaking 10-minute service festival, offering instant bookings for home services including appliance repair, grooming, and domestic help across Indian cities.
NCB grills health staff in Amritsar tramadol racket
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
BESCOM Online Services Down Oct 27-30 - Plan Ahead!
Critical maintenance will disrupt BESCOM's digital services including bill payments and new connections from October 27-30. Bengaluru residents urged to complete urgent electricity-related work beforehand.
CDSCO flags 112 drugs, spurious cough syrup after child deaths
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Dr. Reddy's Q2 Earnings Beat Estimates, Revenue Rises
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
FDA Recalls 140K+ Cholesterol Drug Bottles
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
UP Drug Crackdown: Yogi Orders System Overhaul
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Urban Company Stock Crashes 28%, 24% More Downside Seen
Urban Company shares face massive sell-off as analysts flag overvaluation risks and predict additional 24% downside. Discover what's driving this home services giant's stock collapse.
Page 3 of 4